Infectious Disorders - Drug Targets
Title:Editorial [Hot Topic: B Lymphocytes as Programmers and Effectors of Immunity, their Roles Beyond Antibody Production (Guest Editor: Simon Fillatreau)]
Volume: 12 Issue: 3
Author(s): Simon Fillatreau
Affiliation:
Export Options
About this article
Cite this article as:
Fillatreau Simon, Editorial [Hot Topic: B Lymphocytes as Programmers and Effectors of Immunity, their Roles Beyond Antibody Production (Guest Editor: Simon Fillatreau)], Infectious Disorders - Drug Targets 2012; 12 (3) . https://dx.doi.org/10.2174/187152612800564428
DOI https://dx.doi.org/10.2174/187152612800564428 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Interleukin 1β (IL-1β) and IL-1β/Interleukin 6 (IL-6) Combinations on Drug Metabolizing Enzymes in Human Hepatocyte Culture
Current Drug Metabolism The Therapeutic Effect of Nigella sativa Seed on Indomethacin-induced Gastric Ulcer in Rats
Current Nutrition & Food Science Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets Immunosuppressive and Antiviral Treatment of Inflammatory Cardiomyopathy
Recent Patents on Cardiovascular Drug Discovery Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications
Current Pharmaceutical Design Antisense Treatment in Human Prostate Cancer and Melanoma
Current Cancer Drug Targets Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Counter-Current Chromatography for High Throughput Analysis of Natural Products
Combinatorial Chemistry & High Throughput Screening Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Current Pharmaceutical Design Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis
Current Pharmaceutical Design Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy
Current Topics in Medicinal Chemistry Genipin Inhibits the Induction of Inducible Nitric Oxide Synthase Through the Inhibition of NF-κB Activation in Rat Hepatocytes
Drug Metabolism Letters Polyphenols and Depression: from Chemistry to Medicine
Current Pharmaceutical Biotechnology Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Influenza Viruses: Basic Biology and Potential Drug Targets
Infectious Disorders - Drug Targets The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Current Drug Metabolism Editorial [Hot Topic: Tumor Necrosis Factor (Guest Editor: Francis Ka-Ming Chan)]
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Mechanism of Calcitriol in Cancer Prevention and Treatment
Current Medicinal Chemistry